ST
HZNP

Spot Trading’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Spot Trading’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$257K Buy
20,300
+16,600
+449% +$211K ﹤0.01% 2073
2017
Q2 		$44K Buy
+3,700
New +$46K ﹤0.01% 2852
2017
Q1 		– Sell
-10,000
Closed -$162K – 3504
2016
Q4 		$162K Buy
10,000
+1,200
+14% +$21.8K ﹤0.01% 2024
2016
Q3 		$160K Sell
8,800
-2,900
-25% -$56.7K ﹤0.01% 2217
2016
Q2 		$193K Buy
+11,700
New +$189K ﹤0.01% 2249
2016
Q1 		– Sell
-40,000
Closed -$867K – 4278
2015
Q4 		$867K Buy
40,000
+13,600
+52% +$265K 0.01% 1557
2015
Q3 		$523K Buy
+26,400
New +$834K 0.01% 2022
2015
Q2 		– Sell
-200
Closed -$5K – 4427
2015
Q1 		$5K Buy
+200
New +$3.67K ﹤0.01% 3667

Other funds holding HZNP

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM